Cargando…
P1126: PHASE 1B/2A STUDY OF AZD4573 (CDK9I) AND ACALABRUTINIB IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL)
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430950/ http://dx.doi.org/10.1097/01.HS9.0000971400.47925.e9 |
| _version_ | 1785091082616307712 |
|---|---|
| author | Strati, Paolo Morschhauser, Franck Danilov, Alexey Cheah, Chan Shah, Harsh Jurczak, Wojciech Olabode, Damilola Meyer, Stefanie Lim Yoon, Jeong Arduini, Serena Saeh, Jamal Olsson, Richardp Gregory, Gareth |
| author_facet | Strati, Paolo Morschhauser, Franck Danilov, Alexey Cheah, Chan Shah, Harsh Jurczak, Wojciech Olabode, Damilola Meyer, Stefanie Lim Yoon, Jeong Arduini, Serena Saeh, Jamal Olsson, Richardp Gregory, Gareth |
| author_sort | Strati, Paolo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430950 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309502023-08-17 P1126: PHASE 1B/2A STUDY OF AZD4573 (CDK9I) AND ACALABRUTINIB IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL) Strati, Paolo Morschhauser, Franck Danilov, Alexey Cheah, Chan Shah, Harsh Jurczak, Wojciech Olabode, Damilola Meyer, Stefanie Lim Yoon, Jeong Arduini, Serena Saeh, Jamal Olsson, Richardp Gregory, Gareth Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430950/ http://dx.doi.org/10.1097/01.HS9.0000971400.47925.e9 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Strati, Paolo Morschhauser, Franck Danilov, Alexey Cheah, Chan Shah, Harsh Jurczak, Wojciech Olabode, Damilola Meyer, Stefanie Lim Yoon, Jeong Arduini, Serena Saeh, Jamal Olsson, Richardp Gregory, Gareth P1126: PHASE 1B/2A STUDY OF AZD4573 (CDK9I) AND ACALABRUTINIB IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL) |
| title | P1126: PHASE 1B/2A STUDY OF AZD4573 (CDK9I) AND ACALABRUTINIB IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL) |
| title_full | P1126: PHASE 1B/2A STUDY OF AZD4573 (CDK9I) AND ACALABRUTINIB IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL) |
| title_fullStr | P1126: PHASE 1B/2A STUDY OF AZD4573 (CDK9I) AND ACALABRUTINIB IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL) |
| title_full_unstemmed | P1126: PHASE 1B/2A STUDY OF AZD4573 (CDK9I) AND ACALABRUTINIB IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL) |
| title_short | P1126: PHASE 1B/2A STUDY OF AZD4573 (CDK9I) AND ACALABRUTINIB IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL) |
| title_sort | p1126: phase 1b/2a study of azd4573 (cdk9i) and acalabrutinib in patients (pts) with relapsed/refractory diffuse large b-cell lymphoma (r/r dlbcl) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430950/ http://dx.doi.org/10.1097/01.HS9.0000971400.47925.e9 |
| work_keys_str_mv | AT stratipaolo p1126phase1b2astudyofazd4573cdk9iandacalabrutinibinpatientsptswithrelapsedrefractorydiffuselargebcelllymphomarrdlbcl AT morschhauserfranck p1126phase1b2astudyofazd4573cdk9iandacalabrutinibinpatientsptswithrelapsedrefractorydiffuselargebcelllymphomarrdlbcl AT danilovalexey p1126phase1b2astudyofazd4573cdk9iandacalabrutinibinpatientsptswithrelapsedrefractorydiffuselargebcelllymphomarrdlbcl AT cheahchan p1126phase1b2astudyofazd4573cdk9iandacalabrutinibinpatientsptswithrelapsedrefractorydiffuselargebcelllymphomarrdlbcl AT shahharsh p1126phase1b2astudyofazd4573cdk9iandacalabrutinibinpatientsptswithrelapsedrefractorydiffuselargebcelllymphomarrdlbcl AT jurczakwojciech p1126phase1b2astudyofazd4573cdk9iandacalabrutinibinpatientsptswithrelapsedrefractorydiffuselargebcelllymphomarrdlbcl AT olabodedamilola p1126phase1b2astudyofazd4573cdk9iandacalabrutinibinpatientsptswithrelapsedrefractorydiffuselargebcelllymphomarrdlbcl AT meyerstefanie p1126phase1b2astudyofazd4573cdk9iandacalabrutinibinpatientsptswithrelapsedrefractorydiffuselargebcelllymphomarrdlbcl AT limyoonjeong p1126phase1b2astudyofazd4573cdk9iandacalabrutinibinpatientsptswithrelapsedrefractorydiffuselargebcelllymphomarrdlbcl AT arduiniserena p1126phase1b2astudyofazd4573cdk9iandacalabrutinibinpatientsptswithrelapsedrefractorydiffuselargebcelllymphomarrdlbcl AT saehjamal p1126phase1b2astudyofazd4573cdk9iandacalabrutinibinpatientsptswithrelapsedrefractorydiffuselargebcelllymphomarrdlbcl AT olssonrichardp p1126phase1b2astudyofazd4573cdk9iandacalabrutinibinpatientsptswithrelapsedrefractorydiffuselargebcelllymphomarrdlbcl AT gregorygareth p1126phase1b2astudyofazd4573cdk9iandacalabrutinibinpatientsptswithrelapsedrefractorydiffuselargebcelllymphomarrdlbcl |